论文部分内容阅读
目的:探讨奥美拉唑、阿莫西林、克拉霉素联合治疗幽门螺杆菌感染的临床效果。方法:选取本院2012年1月-2013年12月收治的幽门螺杆菌感染患者70例作为研究对象,随机分为观察组和对照组,每组35例,观察组采用奥美拉唑、阿莫西林、克拉霉素三联方案治疗,对照组采用雷尼替丁、阿莫西林、克拉霉素联合治疗;比较两组治疗效果、不良反应发生率。结果:观察组不良反应发生率、总有效率均均优于对照组(P<0.05)。结论:采用奥美拉唑、阿莫西林、克拉霉素联合治疗幽门螺杆菌感染具有显著的临床效果。
Objective: To investigate the clinical effects of omeprazole, amoxicillin and clarithromycin in the treatment of Helicobacter pylori infection. Methods: Seventy patients with Helicobacter pylori infection admitted from January 2012 to December 2013 in our hospital were randomly divided into observation group (n = 35) and control group (n = 35). The observation group was omeprazole Moxillin and clarithromycin. The control group was treated with ranitidine, amoxicillin and clarithromycin. The therapeutic effect and incidence of adverse reactions were compared between the two groups. Results: The incidence of adverse reactions and total effective rate in the observation group were better than those in the control group (P <0.05). Conclusion: Omeprazole, amoxicillin, clarithromycin combined treatment of Helicobacter pylori infection has a significant clinical effect.